Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells

Cellular and Molecular Life Sciences

Volumn 55, Issue 3, 1999, Pages 456-466

  Li, Q ^a   Zhang, L ^a   Tsang, B ^a   Gardner, K ^a   Bostick Bruton, F ^a   Reed, E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AP 1; ERCC 1 gene transcription; ERCC 1 mRNA; Nucleotide excision repair; Ovarian cancer; Phorbol ester

Indexed keywords

CYCLOHEXIMIDE; DNA BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; DNA REPAIR; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C JUN; OVARY CARCINOMA; PROTEIN DNA BINDING; TRANSCRIPTION REGULATION;

AMANITINS; BINDING SITES; CARCINOGENS; CYCLOHEXIMIDE; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; OVARIAN NEOPLASMS; PROTEIN SYNTHESIS INHIBITORS; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032927651     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050302     Document Type: Article

References (45)

1. Sancar A. (1995) Excision repair in mammalian cells. J. Biol. Chem. 270: 15915-15918
2. Sancar A. (1996) DNA excision repair. Annu. Rev. Biochem. 65: 43-81
3. Cleaver J. E. (1994) It was a very good year for DNA repair. Cell 76: 1-4
4. Friedberg E. C., Walker G. C. and Siede W. (1995) DNA Repair and Mutagenesis, pp. 317-326, ASM Press, Washington, DC
5. Sancar A. (1994) Mechanisms of DNA excision repair. Science 266: 1954-1956
6. Hoeijmakers J. H. J. (1994) Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies. Eur. J. Cancer 30A: 1912-1921
7. Jones J. C., Zhen W., Reed E., Parker R. J., Sancar A. and Bohr V. A. (1991) Preferential DNA repair of cisplatinum lesions in active genes in CHO cells. J. Biol. Chem. 266: 7101-7107
8. Moggs J. G., Yarema K. J., Essigmann J. M. and Wood RD. (1996) Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct. J. Biol. Chem. 271: 7177-7186
9. Sancar A. and Tang M. S. (1993) Nucleotide excision repair. Photochem. Photobiol. 57: 905-921
10. McWhir J., Selfridge J. and Harrison D. J. (1993) Mice with DNA repair gene (ERCC1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet. 4: 217-223
11. Aboussekhra A. (1996) Nucleotide excision repair in vitro and in normal/abnormal human cells. Cell. Pharmacol. 3: 221-224
12. Li L., Elledge S. J., Peterson C. A., Bales E. S. and Legerski R. J. (1994) Specific association between the human DNA repair proteins XPA and ERCC1. Proc. Natl. Acad. Sci. USA 91: 5012-5016
13. Park C.-H. and Sancar A. (1994) Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins. Proc. Natl. Acad. Sci. USA 91: 5017-5021
14. van Duin M., Koken M. H. M., van den Tol J. and Hoeijmakers J. H. J. (1987) Genomic characterization of the human DNA excision repair gene ERCC-1. Nucleic Acids Res. 15: 9195-9213
15. Rolig R. L., Adair G. M. and Nairn R. S. (1998) Defective homologous recombination in a Chinese hamster ovary ERCC-1 knock-out cell line. Proc. Am. Assoc. Cancer Res. 39: 461
16. Dabholkar M., Bostick-Bruton F., Weber C., Bohr V., Egwuagu C. and Reed E. (1992) ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J. Natl. Cancer Inst. 84: 1512-1517
17. Dabholkar M., Vionnet J., Bostick-Bruton F., Yu J. J. and Reed E. (1994) Messenger RNA levels of XPA and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. J. Clin. Invest. 94: 703-708
18. Metzger R., Leichman C. G., Danenberg K. D., Danenberg P. V. and Leichman L. (1998) ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J. Clin. Oncol. 16: 309-316
19. Lee K. B., Parker R. J., Bohr V., Cornelison T. and Reed E. (1993) Cisplatin sensitivity/resistance in UV repair-deficient Chinese hamster ovary cells of complementation groups 1 and 3. Carcinogenesis 14: 2177-2180
20. Cooper G. M. (1995) Oncogenes, 2nd ed., pp. 260-296, Jones and Bartlett Publishers, Boston
21. Abate C., Luk D. and Curran T. (1991) Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains. Mol. Cell. Biol. 11: 3624-3632
22. Gottlicher M., Rahmsdorf H. J. and Herrlich P. (1997) The AP-1 family of transcription factors: multi-level control of activity. In: Transcription Factors in Eukaryotes, pp. 67-93, Papavassiliou A. G. (ed.), Landes Bioscience, Austin, TX
23. Karin M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270: 16483-16486
24. Sassone-Corsi P. (1994) Goals for signal transduction pathways: linking up with transcriptional regulation. EMBO J. 13: 4717-4728
25. Angel P. and Karin M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072: 129-157
26. Albanese C., Johnson J. and Watanabe G. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597
27. Rahmsdorf H. J. (1994) Modulation of Fos and Jun in response to adverse environmental agents. In: The Fos and Jun Families of Transcription Factors, pp. 169-189, Angel P. and Herrlich P. (eds), CRC Press, Boca Raton, FL
28. Li Q., Bostick-Bruton F. and Reed E. (1998) Effect of interleukin-lχ and tumor necrosis factor-χ on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line. Anticancer Res. 18: 2283-2288
29. Li Q., Gardner K., Zhang L., Tsang B., Bostick-Bruton F. and Reed E. (1998) Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells. J. Biol. Chem. 273: 23419-23425
30. Parker R. J., Eastman A., Bostick-Bruton F. and Reed E. (1991) Aquired cisplatin resistance in human ovarian cancer cells is associated with enhanced DNA repair of cisplatin- DNA lesions and reduced drug accumulation. J. Clin. Invest. 87: 773-777
31. Saotome K., Morita H. and Umeda M. (1989) Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs. Toxic. in Vitro. 3: 317-321
32. Chomezynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
33. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
34. Raj N. B. K. and Pitha P. M. (1983) Two levels of regulation of beta-interferon gene expression in human cells. Proc. Natl. Acad. Sci. USA 80: 3923-3927
35. Towbin H., Staehelin T. and Gordon J. (1979) Electophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350-4354
36. Dignam J. P., Lebowitz R. M. and Roeder R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from mammalian nuclei. Nucleic Acids Res. 11: 1475-1489
37. Powers C., Krutzsch H. and Gardner K. (1996) Modulation of JunD-AP-1 DNA binding activity by AP-1-associated factor 1 (AF-1). J. Biol. Chem. 271: 30089-30095
38. Lewin B. (1994) Genes V, pp. 849-851, Oxford University Press, New York
39. Angel P., Imagawa M. and Chiu R. (1987) Phorbol ester inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739
40. Zhen W., Link C. J., O'Connor P. M., Reed E., Parker R. J. and Bohr V. A. (1992) Increased gene-specific repair of cisplatin interstrand crosslinks in cisplatin resistant human ovarian cancer cells. Mol. Cell. Biol. 12: 3689-3698
41. Potapova O., Haghighi A. and Bost F. (1997) The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272: 14041-14044
42. Haas S. and Kaina B. (1995) c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis 16: 985-991
43. Rolig R. L., Layher S. K., Santi B., Gu F. and Nairn R. S. (1997) Survival, mutagenesis and host cell reactivation in a Chinese hamster ovary cell ERCC1 knock-out mutant. Mutagenesis 12: 277-283
44. Schreiber M., Baumann B. and Cotten M. (1995) Fos is an essential component of the mammalian UV response. EMBO J. 14: 5338-5349
45. Liu Z.-G., Baskaran R. and Lea-Chou E. T. (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276